AAAAAA

   
Results: 1-25 | 26-50 | 51-72
Results: 1-25/72
A ROLE FOR IL-15 IN RHEUMATOID-ARTHRITIS
Authors: SHAH MH HACKSHAW KV CALIGIURI MA
Citation: Mh. Shah et al., A ROLE FOR IL-15 IN RHEUMATOID-ARTHRITIS, Nature medicine, 4(6), 1998, pp. 643-643
DETECTION OF MINIMAL RESIDUAL DISEASE IN PATIENTS WITH AML1 ETO-ASSOCIATED ACUTE MYELOID-LEUKEMIA USING A NOVEL QUANTITATIVE REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION ASSAY/
Authors: MARCUCCI G LIVAK KJ BI W STROUT MP BLOOMFIELD CD CALIGIURI MA
Citation: G. Marcucci et al., DETECTION OF MINIMAL RESIDUAL DISEASE IN PATIENTS WITH AML1 ETO-ASSOCIATED ACUTE MYELOID-LEUKEMIA USING A NOVEL QUANTITATIVE REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION ASSAY/, Leukemia, 12(9), 1998, pp. 1482-1489
EVALUATION OF NATURAL-KILLER-CELL EXPANSION AND ACTIVATION IN-VIVO WITH DAILY SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 PLUS PERIODIC INTERMEDIATE-DOSE PULSING
Authors: MEROPOL NJ BARRESI GM FEHNIGER TA HITT J FRANKLIN M CALIGIURI MA
Citation: Nj. Meropol et al., EVALUATION OF NATURAL-KILLER-CELL EXPANSION AND ACTIVATION IN-VIVO WITH DAILY SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 PLUS PERIODIC INTERMEDIATE-DOSE PULSING, Cancer immunology and immunotherapy, 46(6), 1998, pp. 318-326
A REVIEW OF THE ASSOCIATION BETWEEN INTERLEUKIN-10 AND HUMAN B-CELL MALIGNANCIES
Authors: KHATRI VP CALIGIURI MA
Citation: Vp. Khatri et Ma. Caligiuri, A REVIEW OF THE ASSOCIATION BETWEEN INTERLEUKIN-10 AND HUMAN B-CELL MALIGNANCIES, Cancer immunology and immunotherapy, 46(5), 1998, pp. 239-244
INTERLEUKIN-15 AS A POTENTIAL REGULATOR OF THE INNATE IMMUNE-RESPONSE
Authors: CARSON W CALIGIURI MA
Citation: W. Carson et Ma. Caligiuri, INTERLEUKIN-15 AS A POTENTIAL REGULATOR OF THE INNATE IMMUNE-RESPONSE, Brazilian journal of medical and biological research, 31(1), 1998, pp. 1-9
THE PARTIAL TANDEM DUPLICATION OF ALL1 (MLL) IS CONSISTENTLY GENERATED BY ALU-MEDIATED HOMOLOGOUS RECOMBINATION IN ACUTE MYELOID-LEUKEMIA
Authors: STROUT MP MARCUCCI G BLOOMFIELD CD CALIGIURI MA
Citation: Mp. Strout et al., THE PARTIAL TANDEM DUPLICATION OF ALL1 (MLL) IS CONSISTENTLY GENERATED BY ALU-MEDIATED HOMOLOGOUS RECOMBINATION IN ACUTE MYELOID-LEUKEMIA, Proceedings of the National Academy of Sciences of the United Statesof America, 95(5), 1998, pp. 2390-2395
NATURAL-KILLER-CELLS FROM HIV-1(-C CHEMOKINES AND INHIBIT HIV-1 INFECTION() PATIENTS PRODUCE C)
Authors: FEHNIGER TA HERBEIN G YU HX PARA MI BERNSTEIN ZP OBRIEN WA CALIGIURI MA
Citation: Ta. Fehniger et al., NATURAL-KILLER-CELLS FROM HIV-1(-C CHEMOKINES AND INHIBIT HIV-1 INFECTION() PATIENTS PRODUCE C), The Journal of immunology (1950), 161(11), 1998, pp. 6433-6438
DIFFERENTIAL EXPRESSION AND FUNCTION OF L-SELECTIN ON CD56(BRIGHT) AND CD56(DIM) NATURAL-KILLER-CELL SUBSETS
Authors: FREY M PACKIANATHAN NB FEHNIGER TA ROSS ME WANG WC STEWART CC CALIGIURI MA EVANS SS
Citation: M. Frey et al., DIFFERENTIAL EXPRESSION AND FUNCTION OF L-SELECTIN ON CD56(BRIGHT) AND CD56(DIM) NATURAL-KILLER-CELL SUBSETS, The Journal of immunology (1950), 161(1), 1998, pp. 400-408
ULTRA-LOW DOSE INTERLEUKIN-2 THERAPY PROMOTES A TYPE-1 CYTOKINE PROFILE IN-VIVO IN PATIENTS WITH AIDS AND AIDS-ASSOCIATED MALIGNANCIES
Authors: KHATRI VP FEHNIGER TA BAIOCCHI RA YU F SHAH MH SCHILLER DS GOULD M GAZZINELLI RT BERNSTEIN ZP CALIGIURI MA
Citation: Vp. Khatri et al., ULTRA-LOW DOSE INTERLEUKIN-2 THERAPY PROMOTES A TYPE-1 CYTOKINE PROFILE IN-VIVO IN PATIENTS WITH AIDS AND AIDS-ASSOCIATED MALIGNANCIES, The Journal of clinical investigation, 101(6), 1998, pp. 1373-1378
TUMOR-CELL APOPTOSIS, LYMPHOCYTE RECRUITMENT AND TUMOR VASCULAR CHANGES ARE INDUCED BY LOW-TEMPERATURE, LONG-DURATION (FEVER-LIKE) WHOLE-BODY HYPERTHERMIA
Authors: BURD R DZIEDZIC TS XU Y CALIGIURI MA SUBJECK JR REPASKY EA
Citation: R. Burd et al., TUMOR-CELL APOPTOSIS, LYMPHOCYTE RECRUITMENT AND TUMOR VASCULAR CHANGES ARE INDUCED BY LOW-TEMPERATURE, LONG-DURATION (FEVER-LIKE) WHOLE-BODY HYPERTHERMIA, Journal of cellular physiology, 177(1), 1998, pp. 137-147
DETECTION OF UNIQUE ALL1 (MLL) FUSION TRANSCRIPTS IN NORMAL HUMAN BONE-MARROW AND BLOOD - DISTINCT ORIGIN OF NORMAL VERSUS LEUKEMIC ALL1 FUSION TRANSCRIPTS
Authors: MARCUCCI G STROUT MP BLOOMFIELD CD CALIGIURI MA
Citation: G. Marcucci et al., DETECTION OF UNIQUE ALL1 (MLL) FUSION TRANSCRIPTS IN NORMAL HUMAN BONE-MARROW AND BLOOD - DISTINCT ORIGIN OF NORMAL VERSUS LEUKEMIC ALL1 FUSION TRANSCRIPTS, Cancer research, 58(4), 1998, pp. 790-793
REARRANGEMENT OF ALL1 (MLL) IN ACUTE MYELOID-LEUKEMIA WITH NORMAL CYTOGENETICS
Authors: CALIGIURI MA STROUT MP LAWRENCE D ARTHUR DC BAER MR YU F KNUUTILA S MROZEK K OBERKIRCHER AR MARCUCCI G DELACHAPELLE A ELONEN E BLOCK AW RAO PN HERZIG GP POWELL BL RUUTU T SCHIFFER CA BLOOMFIELD CD
Citation: Ma. Caligiuri et al., REARRANGEMENT OF ALL1 (MLL) IN ACUTE MYELOID-LEUKEMIA WITH NORMAL CYTOGENETICS, Cancer research, 58(1), 1998, pp. 55-59
FLT3 LIGAND PROMOTES THE GENERATION OF A DISTINCT CD34(-KILLER-CELL PROGENITOR THAT RESPONDS TO INTERLEUKIN-15() HUMAN NATURAL)
Authors: YU HX FEHNIGER TA FUCHSHUBER P THIEL KS VIVIER E CARSON WE CALIGIURI MA
Citation: Hx. Yu et al., FLT3 LIGAND PROMOTES THE GENERATION OF A DISTINCT CD34(-KILLER-CELL PROGENITOR THAT RESPONDS TO INTERLEUKIN-15() HUMAN NATURAL), Blood, 92(10), 1998, pp. 3647-3657
IMMUNOTHERAPY WITH LOW-DOSE INTERLEUKIN-2 - RATIONALE FOR PREVENTION OF IMMUNE-DEFICIENCY-ASSOCIATED CANCER
Authors: KHATRI VP BAIOCCHI RA BERNSTEIN ZP CALIGIURI MA
Citation: Vp. Khatri et al., IMMUNOTHERAPY WITH LOW-DOSE INTERLEUKIN-2 - RATIONALE FOR PREVENTION OF IMMUNE-DEFICIENCY-ASSOCIATED CANCER, The cancer journal from Scientific American, 3, 1997, pp. 128-136
A PHASE-II STUDY OF DAILY SUBCUTANEOUS (SQ) LOW-DOSE INTERLEUKIN-2 (IL-2) IN HIV-ASSOCIATED MALIGNANCIES
Authors: BERNSTEIN ZP BARRESI G GOULD M POIESZ B CALIGIURI MA
Citation: Zp. Bernstein et al., A PHASE-II STUDY OF DAILY SUBCUTANEOUS (SQ) LOW-DOSE INTERLEUKIN-2 (IL-2) IN HIV-ASSOCIATED MALIGNANCIES, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 96-96
ANALYSIS OF T(H)1 T(H)2 CYTOKINE GENE PROFILE DURING LOW-DOSE IL-2 THERAPY IN PATIENTS WITH AIDS OR AIDS LYMPHOMA/
Authors: KHATRI VP YU F BAIOCCHI RA SHAH MH ZWERLING BH GOULD M BERNSTEIN ZP CALIGIURI MA
Citation: Vp. Khatri et al., ANALYSIS OF T(H)1 T(H)2 CYTOKINE GENE PROFILE DURING LOW-DOSE IL-2 THERAPY IN PATIENTS WITH AIDS OR AIDS LYMPHOMA/, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 99-99
A SUCCESSFUL ENDOGENOUS IMMUNE-RESPONSE TO EPSTEIN-BARR VIRUS-ASSOCIATED MONOCLONAL B-CELL LYMPHOMA
Authors: KHATRI VP BATOCCHI RA HERZIG G CALIGIURI MA
Citation: Vp. Khatri et al., A SUCCESSFUL ENDOGENOUS IMMUNE-RESPONSE TO EPSTEIN-BARR VIRUS-ASSOCIATED MONOCLONAL B-CELL LYMPHOMA, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 122-122
LYMPHOMAGENESIS IN THE SEVERE COMBINED IMMUNE-DEFICIENT MOUSE ENGRAFTED WITH HUMAN-LYMPHOCYTES - CLUES TOWARDS THE PATHOGENESIS AND TREATMENT OF AIDS LYMPHOMA (REVIEW)
Authors: KHATRI VP BAIOCCHI RA BERNSTEIN ZP CALIGIURI MA
Citation: Vp. Khatri et al., LYMPHOMAGENESIS IN THE SEVERE COMBINED IMMUNE-DEFICIENT MOUSE ENGRAFTED WITH HUMAN-LYMPHOCYTES - CLUES TOWARDS THE PATHOGENESIS AND TREATMENT OF AIDS LYMPHOMA (REVIEW), Oncology Reports, 4, 1997, pp. 241-246
INTRODUCTION - ACUTE-LEUKEMIA - RECENT ADVANCES
Authors: BLOOMFIELD CD HERZIG GP CALIGIURI MA
Citation: Cd. Bloomfield et al., INTRODUCTION - ACUTE-LEUKEMIA - RECENT ADVANCES, Seminars in oncology, 24(1), 1997, pp. 1-2
MOLECULAR-BIOLOGY OF ACUTE MYELOID-LEUKEMIA
Authors: CALIGIURI MA STROUT MP GILLILAND DG
Citation: Ma. Caligiuri et al., MOLECULAR-BIOLOGY OF ACUTE MYELOID-LEUKEMIA, Seminars in oncology, 24(1), 1997, pp. 32-44
THE PARTIAL TANDEM DUPLICATION OF ALL1 IN ACUTE MYELOID-LEUKEMIA WITHNORMAL CYTOGENETICS OR TRISOMY-11 IS RESTRICTED TO ONE CHROMOSOME
Authors: CALIGIURI MA STROUT MP OBERKIRCHER AR YU F DELACHAPELLE A BLOOMFIELD CD
Citation: Ma. Caligiuri et al., THE PARTIAL TANDEM DUPLICATION OF ALL1 IN ACUTE MYELOID-LEUKEMIA WITHNORMAL CYTOGENETICS OR TRISOMY-11 IS RESTRICTED TO ONE CHROMOSOME, Proceedings of the National Academy of Sciences of the United Statesof America, 94(8), 1997, pp. 3899-3902
POTENTIAL ROLE FOR INTERLEUKIN-15 IN THE REGULATION OF HUMAN NATURAL-KILLER-CELL SURVIVAL
Authors: CARSON WE FEHNIGER TA HALDAR S ECKHERT K LINDEMANN MJ LAI CF CROCE CM BAUMANN H CALIGIURI MA
Citation: We. Carson et al., POTENTIAL ROLE FOR INTERLEUKIN-15 IN THE REGULATION OF HUMAN NATURAL-KILLER-CELL SURVIVAL, The Journal of clinical investigation, 99(5), 1997, pp. 937-943
CD56(BRIGHT) NATURAL-KILLER-CELL SUBSETS - CHARACTERIZATION OF DISTINCT FUNCTIONAL-RESPONSES TO INTERLEUKIN-2 AND THE C-KIT LIGAND
Authors: CARSON WE FEHNIGER TA CALIGIURI MA
Citation: We. Carson et al., CD56(BRIGHT) NATURAL-KILLER-CELL SUBSETS - CHARACTERIZATION OF DISTINCT FUNCTIONAL-RESPONSES TO INTERLEUKIN-2 AND THE C-KIT LIGAND, European Journal of Immunology, 27(2), 1997, pp. 354-360
STEM-CELL FACTOR ENHANCES INTERLEUKIN-2-MEDIATED EXPANSION OF MURINE NATURAL-KILLER-CELLS IN-VIVO
Authors: FEHNIGER TA CARSON WE MROZEK E CALIGIURI MA
Citation: Ta. Fehniger et al., STEM-CELL FACTOR ENHANCES INTERLEUKIN-2-MEDIATED EXPANSION OF MURINE NATURAL-KILLER-CELLS IN-VIVO, Blood, 90(9), 1997, pp. 3647-3653
DETECTION OF AML1 ETO FUSION TRANSCRIPTS IN PATIENTS WITH T(8-21) ACUTE MYELOID-LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION OR PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION - RESPONSE/
Authors: JURLANDER J CALIGIURI MA BLOOMFIELD CD
Citation: J. Jurlander et al., DETECTION OF AML1 ETO FUSION TRANSCRIPTS IN PATIENTS WITH T(8-21) ACUTE MYELOID-LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION OR PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION - RESPONSE/, Blood, 90(8), 1997, pp. 3231-3231
Risultati: 1-25 | 26-50 | 51-72